|
|
| | Morellic acid Basic information |
| Product Name: | Morellic acid | | Synonyms: | Morellic acid;2-Butenoic acid, 2-methyl-4-[(1R,3aS,5S,14aS)-3a,4,5,7-tetrahydro-8-hydroxy-3,3,11,11-tetramethyl-13-(3-methyl-2-buten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-, (2Z)-;Morellic acid,cell,antiangiogenic,inhibit,Inhibitor,HUVEC | | CAS: | 5304-71-2 | | MF: | C33H36O8 | | MW: | 560.63 | | EINECS: | | | Product Categories: | | | Mol File: | 5304-71-2.mol |  |
| | Morellic acid Chemical Properties |
| Melting point | 94℃ | | Boiling point | 777.6±60.0 °C(Predicted) | | density | 1.36±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in chloroform and DMSO | | form | Powder | | pka | 4.58±0.36(Predicted) |
| | Morellic acid Usage And Synthesis |
| Uses | Morellic Acid is used as a protein tyrosine phosphatase 1B (PTP1B) inhibitor in the treatment of diabetes or cancer. | | target | HIV | Antifection |
| | Morellic acid Preparation Products And Raw materials |
|